ECOG-ACRIN has achieved several milestones in cancer research. Some notable achievements include the development of the Oncotype DX test for breast cancer, which helps determine the necessity of chemotherapy, and the TAPUR Study, which evaluates the use of FDA-approved targeted therapies in treating advanced cancers.
